Advertisement

Enhancing foci on breast MRI: Identifying criteria that increase levels of suspicion

Published:February 07, 2022DOI:https://doi.org/10.1016/j.clinimag.2022.02.001

      Highlights

      • Enhancing foci on breast MRIs sometimes pose diagnostic dilemmas.
      • Foci on screening MRIs may be less suspicious than foci on diagnostic MRIs.
      • Foci in the same quadrant of a known malignancy may be more suspicious.

      Abstract

      Objective

      Prior studies evaluating features of foci associated with malignancy have not been conclusive. This study evaluates foci that were deemed suspicious and assesses multiple imaging and clinical findings with the goal of identifying criteria that can increase diagnostic confidence when evaluating foci on breast MRI.

      Methods

      After Institutional Review Board approval, a retrospective chart review was performed to identify patients who underwent an image-guided biopsy of an enhancing focus. To be included in the study, a breast MRI performed between 2012 and 2019 must have been classified as suspicious for an enhancing focus or foci, and a biopsy using imaging guidance must have been subsequently performed. Patient and imaging characteristics as well as the corresponding biopsy results were recorded and statistically analyzed.

      Results

      There were 74 patients with 85 foci of enhancement who underwent biopsy within the study period. Thirteen of the 85 foci yielded malignant results for an overall positive predictive value of 15.3% (95% confidence interval: 7.7–22.9%). Additionally, twenty-six of the 85 cases (30.6%) yielded high risk lesions. There was a statistically significant negative correlation between screening breast MRIs and biopsies that yielded cancer or atypia (p = 0.04). There was also a significant association between foci and malignant results if the focus was in the same quadrant of a known malignancy (p = 0.001).

      Conclusion

      Clinical information, such as the indication for a breast MRI or the location of a focus relative to a known cancer, can play an important role in evaluating foci of enhancement. Diagnostic confidence in identifying suspicious foci can be aided by incorporating clinical context with imaging findings deemed suspicious by prior research studies.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Imaging
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Morris E.A.
        • Comstock C.E.
        • Lee C.H.
        • et al.
        ACR BI-RADS magnetic resonance imaging.
        in: D'Orsi C.J. Sickles E.A. Mendelson E.B. ACR BI-RADS atlas, breast imaging reporting and data system. American College of Radiology, Reston, VA2013
        • Myers K.S.
        • Oluyemi E.T.
        • Mullen L.A.
        • et al.
        Outcomes of foci on breast MRI: features associated with malignancy.
        AJR. 2020; 215: 1012-1019
        • Raza S.
        • Sekar M.
        • Ong E.M.
        • et al.
        Small masses on breast MR: is biopsy necessary?.
        Acad Radiol. 2012; 19: 412-419
        • Ha R.
        • Sung J.
        • Lee C.
        • et al.
        Characteristics and outcome of enhancing foci followed on breast MRI with management implications.
        Clin Radiol. 2014; 69: 715-720
        • Machida Y.
        • Shimauchi A.
        • Kuroki Y.
        • et al.
        Single focus on breast magnetic resonance imaging: diagnosis based on kinetic pattern and patient age.
        Acta Radiol. 2017; 58: 652-659
        • Jansen S.A.
        • Shimauchi A.
        • Zak L.
        • et al.
        The diverse pathology and kinetics of mass, nonmass, and focus enhancement on MR imaging of the breast.
        J Magn Reson Imaging. 2011; 33: 1382-1389
        • Meissnitzer M.
        • Dershaw D.D.
        • Feigin K.
        • et al.
        MRI appearance of invasive subcentimetre breast carcinoma: benign characteristics are common.
        Br J Radiol. 2017; 90: 20170102
        • Malich A.
        • Fischer D.R.
        • Wurdinger S.
        • et al.
        Potential MRI interpretation model: differentiation of benign from malignant breast masses.
        AJR. 2005; 185: 964-970
        • Liberman L.
        • Mason G.
        • Morris E.A.
        • et al.
        Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion size.
        AJR. 2006; 186: 426-430
        • Han B.-K.
        • Schnall M.D.
        • Orel S.G.
        • et al.
        Outcome of MRI-guided breast biopsy.
        AJR. 2008; 191: 1798-1804
        • Eby P.R.
        • DeMartini W.B.
        • Gutierrez R.L.
        • et al.
        Characteristics of probably benign breast MRI lesions.
        AJR. 2009; 193: 861-867
        • Abe H.
        • Schmidt R.A.
        • Shah R.N.
        • et al.
        MR-directed ("Second-Look") ultrasound examination for breast lesions detected initially on MRI: MR and sonographic findings.
        AJR. 2010; 194: 370-377
        • Weinstein S.P.
        • Hanna L.G.
        • Gatsonis C.
        • et al.
        Frequency of malignancy seen in probably benign lesions at contrast-enhanced breast MR imaging: findings from ACRIN 6667.
        Radiology. 2010; 255: 731-737
        • Van den Bosch M.A.
        • Ikeda D.M.
        • Daniel B.L.
        Does size matter? Likelihood of cancer in MRI-detected lesions less than 5 mm. (letter).
        AJR. 2007; 188 ([web]W571)
        • Clauser P.
        • Cassano E.
        • De Nicolò A.
        • et al.
        Foci on breast magnetic resonance imaging in high-risk women: cancer or not?.
        Radiol Med. 2016; 121: 611-617
        • Liberman L.
        • Morris E.A.
        • Dershaw D.D.
        • et al.
        MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer.
        AJR. 2003; 180: 901-910
        • Rauch G.M.
        • Dogan B.E.
        • Smith T.B.
        • et al.
        Outcome analysis of 9-gauge MRI-guided vacuum-assisted core needle breast biopsies.
        AJR. 2012; 198: 292-299
        • Myers K.S.
        • Kamel I.R.
        • Macura K.J.
        MRI-guided breast biopsy: outcomes and effect on patient management.
        Clin Breast Cancer. 2015; 15: 143-152
        • Ha R.
        • Comstock C.E.
        Breast magnetic resonance imaging: management of an enhancing focus.
        Radiol Clin North Am. 2014; 52: 585-589
        • Rahbar H.
        • Zhang Z.
        • Chenevert T.L.
        • et al.
        Utility of diffusion-weighted imaging to decrease unnecessary biopsies prompted by breast MRI: a trial of the ECOG-ACRIN Cancer Research Group (A6702).
        Clin Cancer Res. 2019; 25: 1756-1765
        • Partridge S.C.
        • Mullins C.D.
        • Kurland B.F.
        • et al.
        Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion typed and size.
        AJR. 2010; 194: 1664-1673